Phase 1 clinical trial of STK-01 in bladder cancer patients.

Trial Profile

Phase 1 clinical trial of STK-01 in bladder cancer patients.

Planning
Phase of Trial: Phase I

Latest Information Update: 07 Jul 2017

At a glance

  • Drugs Docetaxel (Primary)
  • Indications Bladder cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 07 Jul 2017 New trial record
    • 26 Jun 2017 According to a Sitka Biopharma media release, Cancer Research UKs Centre for Drug Development (CDD) will then fund and manage this trial.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top